MARKETS / NASDAQ / ARQ
NASDAQ · MISCELLANEOUS CHEMICAL PRODUCTS · MID CAP

Arq, Inc. ARQ

14 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$120.3M
▲ 10.4% vs FY2024
EPS · FY25
$-1.27
Dividend / sh · FY25
Payout · FY25
ROE · FY25
-27.3%
Net margin · FY25
-43.7%
Dividend coverage
-4.5×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 120.3M
Revenue, FY2025 · full 14-year series below
Revenue Net income
0.040.080.120.160.1-0.1201220152018202120242025
0.040.080.120.160.1-0.12016201920222025

The company lost 44 cents on every revenue dollar this year.

Per share
USD -1.27
Diluted EPS, FY2025
EPS Dividend
246-1.27201220152018202120242025
246-1.272016201920222025

The dividend was paid in a year without profit.

Profitability
-27.3%
Return on equity, FY2025
ROE
100200300400-27.3%201220152018202120242025
100200300400-27.3%2016201920222025
Operating margin-44.0%
Net margin-43.7%
Return on assets-20.4%

Each USD of equity lost 27 cents this year.

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
+12.3% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+5.3%
+12.3%
+6.7%
Dividend / share
−30.7%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.04B
Shares outstanding, FY2025
0.020.04201220152018202120242025
0.020.042016201920222025
Change, 5 years−7.6%
Change, 10 years

The share count shrank 8% in five years — the same company, cut into fewer, larger slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 230.6M
total assets, end of FY2025
Total assetsUSD 230.6M
EquityUSD 168.0M
CashUSD 6.6M
Gross debtUSD 28.5M
Net debtUSD 21.9M
Current ratio1.04×

Net debt stands at 13% of equity.

History
14 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Revenue $B
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.0
0.0
Operating income $B
−0.1
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.1
0.0
0.0
0.0
0.0
Net income $B
−0.1
−0.0
−0.0
−0.0
0.1
−0.0
0.0
0.0
0.0
0.1
−0.0
0.0
−0.0
−0.0
EPS, diluted $
−1.27
−0.14
−0.42
−0.48
3.27
−1.12
1.93
1.76
1.29
4.34
−1.37
0.06
−0.78
−0.65
Dividend / sh $
·
·
·
·
·
0.25
1.00
1.00
0.75
0.00
0.00
·
·
·
Payout %
·
·
−0
−1
0
−25
51
57
56
0
−0
·
·
·
ROE %
−27.3
−2.6
−7.7
−6.2
52.0
−21.0
40.3
50.1
37.3
381.7
·
·
·
·
Shares out B
0.04
0.04
0.03
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
40 of 40
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed